Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Jackson

Showing results (191-200 of 203) with videos related to

Pageof 21
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2020
Phase I, Open-Label, Dose-Escalation/Dose-Expansion Study of Lifirafenib (BGB-283), an RAF Family Kinase Inhibitor, in Patients With Solid TumorsJayesh Desai, Hui Gan, Catherine Barrow, et al.
Gut|June 3, 2020
Colon and rectal cancer survival in seven high-income countries 2010-2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project)Marzieh Araghi, Melina Arnold, Mark J Rutherford, et al.
Gut|June 20, 2020
International trends in oesophageal cancer survival by histological subtype between 1995 and 2014Eileen Morgan, Isabelle Soerjomataram, Anna T Gavin, et al.
The Medical Journal of Australia|May 14, 2020
Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidanceRobert Weinkove, Zoe K McQuilten, Jonathan Adler, et al.
Frontiers in Digital Health|February 12, 2025
Voice EHR: introducing multimodal audio data for healthJames Anibal, Hannah Huth, Ming Li, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2023
Targeting DNA2 Overcomes Metabolic Reprogramming in Multiple MyelomaNatthakan Thongon, Feiyang Ma, Pamela Lockyer, et al.
NPJ Genomic Medicine|August 1, 2018
Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancerBen Lawrence, Cherie Blenkiron, Kate Parker, et al.
The Lancet. Oncology|July 19, 2023
Common Sense Oncology: outcomes that matterChristopher M Booth, Manju Sengar, Aaron Goodman, et al.
Nature Communications|February 8, 2024
Targeting DNA2 overcomes metabolic reprogramming in multiple myelomaNatthakan Thongon, Feiyang Ma, Natalia Baran, et al.
Molecular Biology and Evolution|February 2, 2022
A2B-COVID: A Tool for Rapidly Evaluating Potential SARS-CoV-2 Transmission EventsChristopher J R Illingworth, William L Hamilton, Christopher Jackson, et al.
Pageof 21

Showing results (191-200 of 203) with videos related to

Sort By:
Pageof 21
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2020
Phase I, Open-Label, Dose-Escalation/Dose-Expansion Study of Lifirafenib (BGB-283), an RAF Family Kinase Inhibitor, in Patients With Solid TumorsJayesh Desai, Hui Gan, Catherine Barrow, et al.
Gut|June 3, 2020
Colon and rectal cancer survival in seven high-income countries 2010-2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project)Marzieh Araghi, Melina Arnold, Mark J Rutherford, et al.
Gut|June 20, 2020
International trends in oesophageal cancer survival by histological subtype between 1995 and 2014Eileen Morgan, Isabelle Soerjomataram, Anna T Gavin, et al.
The Medical Journal of Australia|May 14, 2020
Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidanceRobert Weinkove, Zoe K McQuilten, Jonathan Adler, et al.
Frontiers in Digital Health|February 12, 2025
Voice EHR: introducing multimodal audio data for healthJames Anibal, Hannah Huth, Ming Li, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2023
Targeting DNA2 Overcomes Metabolic Reprogramming in Multiple MyelomaNatthakan Thongon, Feiyang Ma, Pamela Lockyer, et al.
NPJ Genomic Medicine|August 1, 2018
Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancerBen Lawrence, Cherie Blenkiron, Kate Parker, et al.
The Lancet. Oncology|July 19, 2023
Common Sense Oncology: outcomes that matterChristopher M Booth, Manju Sengar, Aaron Goodman, et al.
Nature Communications|February 8, 2024
Targeting DNA2 overcomes metabolic reprogramming in multiple myelomaNatthakan Thongon, Feiyang Ma, Natalia Baran, et al.
Molecular Biology and Evolution|February 2, 2022
A2B-COVID: A Tool for Rapidly Evaluating Potential SARS-CoV-2 Transmission EventsChristopher J R Illingworth, William L Hamilton, Christopher Jackson, et al.
Pageof 21